Orally administered corticosteroid compositions
US11246828B2 · kind B2 · utility
5Cited by
33References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2020 |
| Grant date | Feb 15, 2022 |
| Priority date | — |
| Expiry date | Apr 17, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.